Background:Bacterial vaginosis (BV) arises from a disruption in the vaginal microbiome, primarily characterized by a decrease in Lactobacilli and an overgrowth of bacteria like Gardnerella vaginalis. These findings highlight the potential of plant-derived AMPs as novel, effective treatments for BV, offering a pathway to combat antimicrobial resistance and recurrence. Methods:Insilico study was conducted to screen and characterize AMPs from Thymbracapitata and Zataria multiflora, two plants with well-documented medicinal propertiesdesigned to target the ABC transporter permease protein in G. vaginalis, a key contributor to antimicrobial resistance. Structural and physicochemical analyses were conducted to assess peptide stability, hydrophilicity, and membrane interaction potential. Result:Analysis revealed that TCCP-1, a peptide from Thymbracapitata, is more stable and hydrophilic, while ZMLP-2 from Zatariamultiflora exhibits higher hydrophobicity, making it more suited for membrane interactions. These characteristics suggest that these plant-derived peptides have properties favorable for treating BV. Conclusion:Plant-derived antimicrobial peptides (AMPs), especially those from Thymbracapitata and Zataria multiflora, show potential as innovative treatments for bacterial vaginosis (BV), offering a holistic and effective approach while mitigating antimicrobial resistance and recurrence. In silico analysis suggests that the identified transporter in Gardnerella vaginalis is likely an integral membrane protein, a critical insight for docking studies as interactions with membrane-bound proteins differ from those in the cytoplasm or extracellular space. Targeting this protein with AMPs could disrupt cellular transport and division, impairing the pathogen's ability to survive and propagate.
Read full abstract